Select Medical Holdings Corporation
NYSE:SEMMedical - Care Facilities
+$0.02 today
- Market cap
- $2.05B
- Beta
- 0.79
- P/E (TTM)
- 15.3
- EPS (TTM)
- $1.08
- Dividend yield
- 1.51%
Volume 14.27M
Average 1.75M
SEM Financing Cash Flow
Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.
Select Medical Holdings CorporationNYSE: SEM
Financing Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Financing cash flow growth accelerates
Q1 FY2026 financing cash flow of $49.29M rose 0.0% year over year, ahead of the -58.1% change in trailing-twelve-month financing cash flow. Over 3 fiscal years it compounded at +67.2% a year.
Context
- Financing cash flow amounted to 3.0% of revenue in FY2025, down 3.0 pp from a year earlier.
- Financing cash flow grew in size in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +0.0% holds above the trailing-twelve-month pace of -58.1%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Financing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (163.15M) USD
- Year-over-year change
- +47.6%
| Period | Period end | Financing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (163.15M) | +47.6% |
| FY2024 | 2024-12-31 | (311.17M) | +5.0% |
| FY2023 | 2023-12-31 | (327.48M) | -838.6% |
| FY2022 | 2022-12-31 | (34.89M) | +94.6% |
| FY2021 | 2021-12-31 | (647.39M) | — |
Financing Cash Flow vs competitors
How SEM compares with its peers on the latest reported figures
- SEM's LTM Mar 2026 financing cash flow of $166.09M is the 4th largest of the 11 companies compared; the peer median is $19.09M.
- Its year-over-year change of -58.1% is the 9th highest of 11, against a peer median of +267.2%.
- Financing cash flow amounts to 3.0% of revenue for SEM, versus a peer median of 3.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $597.53M | +3986.4% | — | 16.9% | |
| LTM Sep 2026 | $384.41M | +443.1% | +41.8% | 24.3% | |
| LTM Sep 2026 | $234.94M | +436.2% | -39.6% | 12.0% | |
| LTM Mar 2026 | $166.09M | -58.1% | +67.2% | 3.0% | |
| LTM Jun 2026 | $127.85M | +606.1% | — | 8.1% | |
ARDTArdent Health Partners, LLC | LTM Mar 2026 | $98.85M | -437.4% | -27.4% | 1.5% |
| LTM Mar 2026 | $81.23M | +51.0% | +17.6% | 4.4% | |
| LTM Oct 2026 | $35.37M | +13650.2% | -55.7% | 1.3% | |
| LTM Sep 2026 | $28.62M | -92.2% | — | 0.8% | |
| LTM Mar 2026 | $24.4M | +4.5% | — | 3.3% | |
| LTM Jun 2026 | $13.79M | +98.3% | — | 1.4% | |
| Peer median (excluding SEM) | $19.09M | +267.2% | -27.4% | 3.9% | |
Competitors are the stored peer set for SEM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 499.95M | 198.03M | 299.73M | 296.7M | 146.22M |
| Depreciation & Amortization | 202.65M | 205.83M | 208.74M | 203.89M | 140.3M |
| Deferred Income Tax | 5.06M | 7.52M | (16.12M) | (32.43M) | 30.65M |
| Stock-Based Compensation | 30.94M | 37.76M | 43.81M | 100.67M | 16.7M |
| Change in Working Capital | (329.98M) | (159.54M) | 59.5M | (55.14M) | (59.68M) |
| Accounts Receivables | 23.1M | (52.18M) | 1.16M | (95.85M) | (45.19M) |
| Inventory | (82.77M) | 0 | 0 | 0 | 0 |
| Accounts Payables | 53.39M | (48.04M) | (6.41M) | (16.79M) | (854K) |
| Other Working Capital | (323.7M) | (59.31M) | 64.75M | 57.5M | (13.64M) |
| Other Non-Cash Items | (7.38M) | (4.76M) | (13.6M) | 4.17M | 72.27M |
| Operating Cash Flow | 401.23M | 284.83M | 582.06M | 517.86M | 346.47M |
| Capital Expenditures | (180.54M) | (190.37M) | (229.2M) | 21.78M | 36.27M |
| Acquisitions (Net) | (102.88M) | (44.31M) | (39.44M) | (13.1M) | (9.2M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 26.82M | 8.34M | 163K | 4.26M | (243.56M) |
| Investing Cash Flow | (256.59M) | (226.34M) | (268.48M) | (231.01M) | (216.49M) |
| Debt Repayment | 195.7M | 264.68M | (203.95M) | (493.46M) | 42.34M |
| Common Stock Issued | 0 | 0 | 0 | 511.2M | 0 |
| Common Stock Repurchased | (79.48M) | (195.53M) | (12.76M) | (37.91M) | (100.08M) |
| Dividends Paid | (50.6M) | (64.59M) | (63.9M) | (64.62M) | (31.44M) |
| Other Financing Activities | (713.01M) | (39.45M) | (46.86M) | (226.38M) | (73.98M) |
| Financing Cash Flow | (647.39M) | (34.89M) | (327.48M) | (311.17M) | (163.15M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (502.75M) | 23.6M | (13.9M) | (24.31M) | (33.17M) |
| Free Cash Flow | 220.69M | 94.45M | 352.86M | 539.65M | 382.74M |
Select Medical Holdings Corporation
NYSE:SEM
Intrinsic Alpha fair value
Locked
Current Price
$16.51
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.